More people are having problems with their lungs. As the population ages, and with more women smoking in the past 50 years, chronic respiratory diseases are on the rise. Doctors are seeing more instances of lung cancer and chronic obstructive pulmonary disease than ever before. Now St. Michael’s has the tool to diagnose these complications sooner.
Donors contributed $303,000 to bring the innovative Endobronchial ultrasound (EBUS) to St. Michael’s, making the hospital the first to use this technology to help people with respirology conditions.
Now their [donor] support means we can pinpoint lung cancer faster and do something before it’s too late.
How does EBUS work?
EBUS uses an endoscopic probe to see inside the bronchi or airways of the lung. This is the most efficient and accurate method for diagnosing lung cancer in a way that’s minimally invasive.
“With EBUS, we can provide, at the start, 30 patients a month with state-of-the-art diagnosis for respiratory problems available nowhere else in Toronto,” says Dr. Victor Hoffstein, a staff respirologist at St. Michael’s. “And as our team’s expertise grows, so will the number of patients who benefit.”
Special thanks to all of the donors who helped bring EBUS to St. Michael’s and volunteers Ted Macklin and Tim Griffin.
“It was wonderful to see how excited people got about the innovative potential of the technology,” says Dr. Hoffstein. “Now their support means we can pinpoint lung cancer faster and do something before it’s too late.”